Skip to main content
. 2003 Oct;56(4):407–414. doi: 10.1046/j.1365-2125.2003.01904.x

Figure 1.

Figure 1

Population pharmacokinetic model predictions and observed concentrations of enoxaparin (anti-Xa). ——, Population prediction (typical patient); - - - - -, individual predictions (5th, 50th (median), 95th percentiles of 1000 patients). 0 refers to the time of dosing.